Reverse Axillary Mapping in Breast Radiation Treatment Planning

UNC Lineberger Comprehensive Cancer Center

Status: Withdrawn

Conditions: Breast Cancer; Lymphedema

Study type: Observational

Funder types: Other

Identifiers

NCT04292860

LCCC1934

Details and patient eligibility

About

The goal of this prospective study is to investigate the role of axillary reverse mapping (ARM) in radiation therapy planning of patients with breast cancer. Lymphedema is a common side effect after surgery and radiation therapy for breast cancer. The use of ARM is becoming more routine in surgery to differentiate the upper extremity lymphatics (UELs) from the breast axillary drainage to preferentially spare the UELs and reduce the rates of lymphedema.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• De novo presentation of post-operative (lumpectomy or mastectomy) female breast cancer patients to receive radiation to the whole breast or chest wall and the regional nodes. Patients who have received a sentinel lymph node (SLN) biopsy or an axillary lymph node dissection (ALND) will be eligible.
• Greater than or equal to 18 years of age (no upper age limit).
• Informed consent obtained.

Exclusion criteria

• Prisoners.
• Patients with metastatic breast cancer.
• Documented allergy to iodinated contrast
• Prior breast or axillary surgeries or radiation.

Trial design

0 participants in 1 patient group

Breast Cancer Pts

Description:

Post-operative (lumpectomy or mastectomy) female breast cancer patients who will receive radiation to the whole breast or chest wall and the regional nodes.